Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology Inc (NQ: NAUT )

2.460 -0.010 (-0.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,184
Open 2.520
Bid (Size) 2.410 (5)
Ask (Size) 2.700 (2)
Prev. Close 2.470
Today's Range 2.426 - 2.640
52wk Range 2.160 - 4.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
-18.54%
-18.54%
1 Month
-6.11%
-6.11%
3 Month
-19.34%
-19.34%
6 Month
-8.55%
-8.55%
1 Year
-12.14%
-12.14%

More News

Read More
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Williams-Sonoma, ESS Tech And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Sink; Deere Shares Fall Despite Earnings Beat
Via Benzinga
Topics Stocks
Exposures US Equities
Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Top 5 Health Care Stocks That May Crash This Month
Via Benzinga
Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports First Quarter 2023 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.